Stryker Corp 8-K, filed Feb 19, 2025
Stryker Corp (SYK)
About this 8-K
Stryker Corp filed this 8-K on February 19, 2025.
Items reported
- Item 2.01: Completed an acquisition or sale of assets
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
||||
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code:
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.01 | Completion of Acquisition or Disposition of Assets |
On February 19, 2025, Stryker Corporation, a Michigan corporation (“Stryker”), and Eagle 1 Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Stryker, completed the acquisition of Inari Medical, Inc., a Delaware corporation (“Inari”), pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of January 6, 2025 (the “Merger Agreement”), among Stryker, Inari, and, following its execution and delivery of a joinder thereto on January 7, 2025, Merger Sub. At the closing, Merger Sub merged with and into Inari pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with Inari continuing as the surviving corporation. The total aggregate consideration paid by or on behalf of Stryker and Merger Sub in the transaction was approximately $4.94 billion in cash.
The foregoing description of the Merger Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Merger Agreement, which Stryker filed as Exhibit 2.1 to its Current Report on Form 8-K dated January 7, 2025.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| STRYKER CORPORATION | ||||||
| (Registrant) | ||||||
| Dated: February 19, 2025 | By: | /s/ Glenn S. Boehnlein | ||||
| Name: | Glenn S. Boehnlein | |||||
| Title: | Vice President, Chief Financial Officer | |||||